LON:DEST - Destiny Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 64 0.00 (0.00 %)
(As of 01/18/2019 04:00 PM ET)
Previous CloseGBX 64
Today's RangeGBX 64 - GBX 64
52-Week RangeGBX 111 - GBX 235
Average Volume4,205 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Destiny Pharma plc, a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of novel medicines for the treatment of infectious diseases in the United Kingdom. It is involved in developing XF-73 Nasal for the treatment of post-surgical staphylococcal infections; XF-73 Throat for the treatment of staphylococcal hospital/ventilator pneumonia infections; XF-70 Dermal for the treatment of skin burn wound infections of antibiotic resistant bacteria; and XF-70 Lung for the treatment of bacterial biofilm-associated infections. The company has collaboration agreement with China Medical System Holdings Limited; and research collaboration with the University of Southampton for targeting infections in diabetic foot ulcers and cystic fibrosis. The company was incorporated in 1996 and is headquartered in Brighton, the United Kingdom.

Receive DEST News and Ratings via Email

Sign-up to receive the latest news and ratings for DEST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A




Destiny Pharma (LON:DEST) Frequently Asked Questions

What is Destiny Pharma's stock symbol?

Destiny Pharma trades on the London Stock Exchange (LON) under the ticker symbol "DEST."

How were Destiny Pharma's earnings last quarter?

Destiny Pharma PLC (LON:DEST) posted its quarterly earnings data on Thursday, April, 12th. The company reported ($8.40) EPS for the quarter, missing the Zacks' consensus estimate of ($8.30) by $0.10. View Destiny Pharma's Earnings History.

What price target have analysts set for DEST?

0 Wall Street analysts have issued 1 year target prices for Destiny Pharma's stock. Their forecasts range from GBX 250 to GBX 250. On average, they anticipate Destiny Pharma's share price to reach GBX 250 in the next twelve months. This suggests a possible upside of 290.6% from the stock's current price. View Analyst Price Targets for Destiny Pharma.

Has Destiny Pharma been receiving favorable news coverage?

News stories about DEST stock have been trending somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Destiny Pharma earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.

Who are some of Destiny Pharma's key competitors?

Who are Destiny Pharma's key executives?

Destiny Pharma's management team includes the folowing people:
  • Mr. Neil Robert Clark, CEO & Director (Age 56)
  • Dr. William Guy Love, Founder, Chief Scientific Officer & Director (Age 56)
  • Mr. Shaun Claydon, CFO, Company Sec. & Director (Age 51)
  • Dr. Jesús M González Moreno, Chief Medical Officer
  • Dr. William Rhys-Williams, Project Director of Microbiology & Pre-Clinical Devel. (Age 51)

How do I buy shares of Destiny Pharma?

Shares of DEST and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Destiny Pharma's stock price today?

One share of DEST stock can currently be purchased for approximately GBX 64.

What is Destiny Pharma's official website?

The official website for Destiny Pharma is https://www.destinypharma.com/.

How can I contact Destiny Pharma?

Destiny Pharma's mailing address is Sussex Innovation Centre Science Park Square, Falmer, BRIGHTON, BN1 9SB, United Kingdom. The company can be reached via phone at +44-1273-704440.

MarketBeat Community Rating for Destiny Pharma (LON DEST)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Destiny Pharma and other stocks. Vote "Outperform" if you believe DEST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DEST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel